✦ LIBER ✦

PSS7 THE ECONOMIC COST OF TREATING PATIENTS WITH AGE-RELATED MACULAR DEGENERATION IN SPAIN

✍ Scribed by J Darba; L Kaskens

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PSS15 THE COST-EFFECTIVENESS OF RANIBIZU

✍ A Turpcu; JW Hay 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

PSS13 COST-EFFECTIVE ANALYSIS OF PEGAPTA

✍ LY Lu; W McGhan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PSS5 HEALTH RESOURCE UTILIZATION AND COS

✍ Ruamviboonsuk, P; Ratanasukon, M; Dilokthornsakul, P; Chanatittarat, C; Pokawatt 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PSS12 ECONOMIC EVALUATION OF RANIBIZUMAB

✍ N Maniadakis; K Athanasakis; V Fragoulakis; V Tsiantou; J Kyriopoulos 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Delay in treating age-related macular de

✍ Arias, L; Armadá, F; Donate, J; García-Arumí, J; Giralt, J; Pazos, B; Piñero, A; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 126 KB

Cost-Effectiveness of Intravitreal Aflib

✍ Clements, K.M.; Hulbert, E.M.; Panchmatia, H.R.; Eriksson, M.; Wittrup-Jensen, K 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB